Company Overview of Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals, LLC licenses, acquires, develops, and commercializes over-the-counter drug and device products for consumer and healthcare markets. The company offers MyClyns, a non-alcohol personal protection spray that is used on face when exposed to harmful pathogens; and respirators that are used against airborne microorganisms. It also offers ExtendaClyns, a non-alcohol foam that is a hand sanitizer and a first aid antiseptic. The company was founded in 2007 and is based in Erlanger, Kentucky. Union Springs Pharmaceuticals, LLC operates as a subsidiary of the Xanodyne Pharmaceuticals, Inc.
4157 Olympic Boulevard
Erlanger, KY 41018
Founded in 2007
Key Executives for Union Springs Pharmaceuticals, LLC
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Union Springs Pharmaceuticals, LLC, please visit myclyns.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.